Together, these results define the TGFβ/EPHA4 signaling axis as a critical regulator of breast cancer cellular migration, tumor aggressiveness and poor patient outcomes and highlight EPHA4 as a potential new prognostic marker for basal-like breast tumors. Here, TGFB1 is linked to breast carcinoma.